We all know that specialty medicines, which are being developed to provide treatments for chronic, rare, and life-threatening diseases, take up a greater share of the pharmaceutical market. With this in mind, specialty pharmacy billing, being as cumbersome as the treatments it advocates, is no more a secret; thus, while revolutionary, the treatments become rather challenging to both HCPs, patients, and pharmacies undertaking their dispensation.